Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients

•Elevated troponin levels are one of the common phenomena in COVID-19 patients.•COVID-19 patients with elevated troponin have limited benefit from Paxlovid monotherapy.•Cardiac troponin levels should be closely monitored in patients treated with Paxlovid.

Saved in:
Bibliographic Details
Published in:The Journal of infection 2023-08, Vol.87 (2), p.148-150
Main Authors: Zhao, Deze, He, Yi, Dian, Yating, Meng, Yu, Zeng, Furong, Deng, Guangtong
Format: Article
Language:English
Subjects:
COVID-19
Hospitalization
Humans
SARS-CoV-2
Troponin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Elevated troponin levels are one of the common phenomena in COVID-19 patients.•COVID-19 patients with elevated troponin have limited benefit from Paxlovid monotherapy.•Cardiac troponin levels should be closely monitored in patients treated with Paxlovid.
ISSN:0163-4453
1532-2742
DOI:10.1016/j.jinf.2023.03.026